Kavita Ravindra Chandak

Kavita Ravindra Chandak

Active Director Director DIN 08991137
DIN 08991137 First appointment Dec 2020 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Kavita Ravindra Chandak

Data last updated:

Kavita Ravindra Chandak is a Director at Gajanan Prasanna Pharmaceuticals Private Limited (since 2020). The company operates in Business Services.

DIN 08991137
Primary Designation Director
Industry Business Services
First Appointment 10 Dec 2020
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Dec 20202020Active

Board colleagues of Kavita Ravindra Chandak

Directorship timeline

Open interactive timeline →
Gajanan Prasanna Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kavita Ravindra Chandak

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kavita Ravindra Chandak

Kavita Ravindra Chandak currently holds 1 directorship: Gajanan Prasanna Pharmaceuticals Private Limited (Director, since 10 Dec 2020).

Kavita Ravindra Chandak was first appointed on 10 Dec 2020 as Director at Gajanan Prasanna Pharmaceuticals Private Limited.

The current boards of Kavita Ravindra Chandak's companies include Ravindra Ramankishor Chandak (Gajanan Prasanna Pharmaceuticals Private Limited), Reeshabh Ravindra Chandak (Gajanan Prasanna Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available